Patient Complications after Interscalene Block: A Retrospective Comparison of Liposomal Bupivacaine to Nonliposomal Bupivacaine

Table 2

Varying medication combinations in the liposomal bupivacaine group.

Drug combination	Volume (mL) range	Volume (mL) median	Number missing
LB + 0.25% bupivacaine (N = 130)
LB	5–20	10	2
0.25% bupivacaine	2–20	10	1
LB + 0.25% bupivacaine plus epinephrine (N = 229)
LB	5–20	10	1
0.25% bupivacaine plus epinephrine	2–25	10	0
LB + 0.5% bupivacaine (N = 118)
LB	5–20	10	1
0.5% bupivacaine	3–20	10	0
LB + 0.5% bupivacaine plus epinephrine (N = 225)
LB	7.5–20	10	0
0.5% bupivacaine plus epinephrine	3–20	10	0
LB only (N = 79)
LB	10–20	15	0
LB + 0.5% ropivacaine plus clonidine plus epi (N = 3)
LB	10–15	10	0
0.5% ropivacaine plus clonidine plus epi	10–15	10	0

LB: liposomal bupivacaine; N: the number of patients included in that group.